Posted on 9/25/17
Johnson & Johnson Vs. Pfizer: Which Is A Better Buy?
Johnson & Johnson and Pfizer are among leading pharmaceutical companies in the world seeking to further grow their revenue.Both companies are able to grow its dividend . . .
Posted on 9/25/17
J&J: Thoughts On Sirukumab And Other Problems
BackgroundIn my 8 articles on Johnson & Johnson (NYSE:JNJ) over the past 3 1/2 years, I have alternated between liking the stock and being neutral on . . .
Posted on 9/25/17
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Based on recent history, Celgene Corporation (NASDAQ:CELG) and Merck & Co.(NYSE:MRK) stocks don't even belong in the same league. Celgene stock is up more than 270% . . .
Posted on 9/25/17
Better Buy: Kimberly-Clark Corp. vs. Johnson & Johnson
There aren't many companies that can grow sales and profits through a wide range of market conditions. But both Kimberly-Clark (NYSE:KMB), the consumer goods specialist, and . . .
Posted on 9/25/17
J&J: Thoughts On Sirukumab And Other Problems
Johnson & Johnson has become an expensive stock with limited growth prospects.Its appeal has centered around dividend growth prospects (aka bond substitute) anchored by an AAA . . .
Posted on 9/22/17
Krystal Biotech Closes IPO
PITTSBURGH, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from . . .
Posted on 9/22/17
Johnson & Johnson Acquires Sightbox
Quick TakeJohnson & Johnson Vision Care (JNJ) announced that it has acquired Sightboxfor an undisclosed amount.Sightbox has created a subscription membership service for contact lens wearers . . .
Posted on 9/22/17
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer (NYSE:PFE) took direct aim at Johnson & Johnson (NYSE:JNJ) last year when it won FDA approval for Inflectra, a biosimilar to Johnson & Johnson's multi-billion . . .
Posted on 9/21/17
Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets
Provention Bio, Inc., a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics aimed at intercepting and preventing immune-mediated diseases, announced today that . . .
Posted on 9/21/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 18, 2017 it approved non-statutory stock options to purchase an aggregate of 32,500 shares of its . . .
Posted on 9/21/17
AmeriHealth Caritas Pennsylvania is the Top Rated Medicaid Plan in Pennsylvania
HARRISBURG, Pa.--(BUSINESS WIRE)--AmeriHealth Caritas Pennsylvania, a Medical Assistance (Medicaid) managed care plan serving central and northwestern Pennsylvania and part of the AmeriHealth Caritas Family of Companies, . . .
Posted on 9/21/17
AmerisourceBergen Entering Buying Territory
Sentiment in AmerisourceBergen Corp.(NYSE:ABC) is getting pretty pessimistic once more and value investors are wondering whether we may have a possible value play on the cards . . .
Posted on 9/21/17
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer (NYSE:PFE) took direct aim at Johnson & Johnson (NYSE:JNJ) last year when it won FDA approval for Inflectra, a biosimilar to Johnson & Johnson's multi-billion . . .
Posted on 9/20/17
Adfinitas Health Selects Continuum as their Revenue Cycle Management Partner
Adfinitas Health, the largest private hospitalist group in the Mid-Atlantic region, has selected Continuum Health, a value-based care strategy and management company, as their revenue cycle . . .
Posted on 9/20/17
Teva - More Sales, Mind The Proceeds
Teva (TEVA) makes great progress in addressing its troubles after it really became evident in recent months that the $40-billion acquisition of the generics business of . . .
Posted on 9/20/17
Krystal Biotech Prices Upsized IPO
PITTSBURGH, Pa., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from . . .
Posted on 9/20/17
Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced the pricing of its underwritten public offering . . .
Posted on 9/19/17
Johnson & Johnson's Dividend Will Continue To Chug Along, But Likely At A Slower Pace
Johnson & Johnson is a dividend stalwart. The recent dividend raise led me to question whether this was a one-time event or the beginning of lower . . .
Posted on 9/19/17
New Mazzoni Center Healthcare and Social Services Community Center By Coscia Moos Architecture Opens in Philadelphia
A new Mazzoni Center comprehensive LGBTQ healthcare and social services community center opened at Broad and Bainbridge Streets in Philadelphia, Pa. Designed by Coscia Moos Architecture, . . .
Posted on 9/19/17
Billionaire George Soros' Fund Bought These 3 Pharma Stocks: Should You?
Billionaire George Soros is an iconic figure in the world of investing because of his unique ability to consistently beat the broader markets. As such, the . . .
Posted on 9/19/17
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017
There is perhaps no scarier word in the English language than "cancer." More than 15.5 million Americans who were alive as of Jan. 1, 2016, have . . .
Posted on 9/19/17
Teva Pharmaceutical: An Opportunity Or A Falling Knife? (Part 2)
It was exactly six weeks ago (Aug. 7) when I defined Teva Pharmaceutical (NYSE:TEVA) as a long-term opportunity, despite it possibly being a short-term falling knife. . . .
Posted on 9/19/17
Teva: Is $1.1 Billion Asset Sale Much Ado About Nothing?
Teva new CEO Kare SchultzTeva (TEVA) has had some exciting news to present over the past week. It hired 30-year industry veteran Kare Schultz as its . . .
Posted on 9/19/17
3 High-Yield Healthcare Stocks
One downside to a long-lasting bull market is that the market's dividend yield declines. That's a big problem for retirees who rely on their portfolio to . . .
Posted on 9/18/17
PMD Healthcare Announces Collaboration with OptiMed Specialty Pharmacy
PMD Healthcare of Allentown, Penn., and OptiMed Specialty Pharmacy of Kalamazoo, Mich., have announced a business partnership to offer a strategic hub service that expedites and . . .

